Braidwell is a Stamford-based venture capital firm and flexible capital provider focused on companies transforming human health across public and private markets. It invests across stages and parts of the capital structure, has acted as a co-lead investor, and is most relevant for biotechnology, life sciences, pharmaceuticals, medical devices, oncology and broader HealthTech companies in the United States.